Skip to main content

Table 2 Clinical variables and psychopharmacological treatment in OCD patients, with or without MDD comorbidity

From: Sleep disturbances in obsessive-compulsive disorder: influence of depression symptoms and trait anxiety

  OCD without MDD
(N = 35)
OCD with MDD
(N = 26)
Statistic df P value
Clinical Variables
 HAM-D-17 6.67 (4.22) 10.04 (5.87) t = −2.62 59 0.01*
 Y-BOCS 22.55 (6.06) 22.13 (4.46) t = 0.29 59 0.77
 STAI-Trait 35.11 (9.82) 34.7 (13.50) t = 0.14 59 0.89
 STAI-State 26.40 (14.40) 26.04 (16.11) t = 0.09 59 0.93
Psychopharmacological Treatment Doses (DDD)
 SSRI 3 (1.80) 3.12 (2.44) t = −0.21 59 0.83
 Dual-action antidepressants 0.09 (0.35) 0.38 (0.91) t = −1.72 59 0.09
 TCA 0.66 (0.91) 0.65(0.90) t = 0.07 59 0.95
 Other antidepressants 0.01 (0.08) 0.04 (0.20) t = −0.65 59 0.52
 Benzodiazepines (diazepam equivalents mg/day) 3.47 (6.75) 8.44 (9.35) t = −2.41 59 0.02*
 Antipsychotics (chlorpromazine equivalents mg/day) 64.86 (116.22) 52.31 (109.70) t = 0.43 59 0.67
  1. Data are mean (SD). Abbreviations: OCD Obsessive-Compulsive Disorder, MDD Major Depressive Disorder, HAM-D Hamilton Depression Rating Scale, Y-BOCS Yale-Brown Obsessive Compulsive Scale, STAI State-Trait Anxiety Inventory, DDD defined daily doses, SSRI selective serotonin reuptake inhibitors, TCA tricyclic antidepressants
  2. *P < 0.05